Pharmaceutical industry
The stock market rally persisted on Monday, despite Monday's Nasdaq and S&P 500 losses, with Alphabet, Blackstone, CF Industries, and Cheniere Energy being highlighted as top stocks to buy and watch. These companies are in or near new buy zones, according to Investors Business Daily (IBD)
Pharmaceutical industry
GlaxoSmithKline's ViiV Healthcare, a global specialist HIV company, has reached a settlement with Gilead Sciences in a patent infringement case over the antiretroviral medication dolutegravir. The dispute centered on Gilead's Biktarvy, a triple combination HIV medicine containing bictegravir, which was allegedly infringing on ViiV Healthcare'
Pharmaceutical industry
The vitamin D market is expected to witness significant growth in the coming years, driven by increasing awareness about the importance of vitamin D, growing demand for health supplements, and strong presence of key vendors in the market. According to a recent market study by Technavio, the vitamin D market
Pharmaceutical industry
Researchers from Japan have conducted a prospective, observational study to evaluate the safety of the SARS-CoV-2 vaccine in patients with advanced lung cancer receiving anticancer therapy. The study, published in Thoracic Cancer, aimed to assess the occurrence of early adverse events within 7 days of vaccine injection in patients undergoing
Pharmaceutical industry
The past week has seen significant developments in the regulatory affairs space, with updates on FDA approvals, rejections, and guidance, as well as the ongoing COVID-19 pandemic. The US FDA has approved the use of antiviral drug remdesivir as an outpatient therapy for people with COVID-19, while also rejecting Merck&
Pharmaceutical industry
Pharma companies continued to evolve their advertising strategies in 2021, as both COVID-19 vaccines and autoimmune treatments dominated the landscape. While AbbVie's Humira maintained a high level of spending, it took a hit from Pfizer's COVID-19 vaccine and was ultimately surpassed by Sanofi and Regeneron'
Pharmaceutical industry
The drug discovery industry has been significantly impacted by the COVID-19 pandemic, with temporary breaks in clinical trials and a shift towards remote and virtual study methods. However, the pandemic has also led to the emergence of new working ways, and technological advancements are simplifying the complex procedures in drug
Pharmaceutical industry
Pfizer, the American multinational pharmaceutical corporation, has announced that a COVID-19 vaccine targeting the Omicron variant will be ready by March, as Omicron now accounts for more than 98% of all new COVID-19 cases in the United States. Meanwhile, Moderna, another leading pharmaceutical company, is also developing an Omicron-specific vaccine,
Pharmaceutical industry
The Irish government has confirmed that it is pursuing the purchase of COVID-19 antiviral and monoclonal antibody treatments, following discussions at a cabinet meeting. The treatments in question are manufactured by Pfizer, GlaxoSmithKline (GSK), and Merck (MSD). Ireland has already indicated its intention to participate in a European Union (EU)
Pharmaceutical industry
The Chronic Kidney Disease market is expected to reach $24.8 billion by 2026, growing at a CAGR of 6.6% during the forecast period. The market is driven by the increasing incidence of chronic kidney diseases, technological advancements in diagnostic tests, and the rising need for early detection. The
Pharmaceutical industry
The "Chronic Kidney Disease Market - Growth, Trends, COVID-19 Impact, and Forecasts (2021 - 2026)" report projects a significant growth in the Chronic Kidney Disease Market, with an expected Compound Annual Growth Rate (CAGR) of 6.6% during the forecast period. The market is driven by the increasing
Pharmaceutical industry
The Food and Drug Administration is poised to approve Pfizer-BioNTech's COVID-19 booster shots for 12-to-15-year-olds, pending a recommendation from unnamed sources familiar with the decision. The booster will be recommended five months after the older children receive their second vaccine, a departure from the six months currently advised
